Skip to Content

Atrion Corp ATRI

Morningstar Rating
$457.73 +0.63 (0.14%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ATRI is trading at a 430% premium.
Price
$458.00
Fair Value
$283.66
Uncertainty
Very High
1-Star Price
$133.40
5-Star Price
$952.52
Economic Moat
Tjvwnc
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATRI is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$457.10
Day Range
$457.38458.00
52-Week Range
$274.98576.00
Bid/Ask
$451.45 / $458.50
Market Cap
$805.58 Mil
Volume/Avg
17,278 / 31,335

Key Statistics

Price/Earnings (Normalized)
39.15
Price/Sales
4.56
Dividend Yield (Trailing)
1.93%
Dividend Yield (Forward)
1.93%
Total Yield
2.06%

Company Profile

Atrion Corp develops and manufactures products for medical applications. Its fluid-delivery products contribute the largest proportion of revenue and include valves that can hold and release controlled amounts of fluids or gases and are often used in anesthesia and oncology applications. Atrion's cardiovascular products include the MPS2 Myocardial Protection System, which delivers fluids and medications, mixes drugs, and controls temperature and pressure during open-heart surgery. The cardiovascular business also sells cardiac-surgery vacuum relief valves, inflation devices, and other products used in heart surgery. The firm's ophthalmic products include medical devices that disinfect contact lenses. Atrion generates the majority of revenue in the United States.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Core
Total Number of Employees
712

Comparables

Valuation

Metric
ATRI
MMSI
STAA
Price/Earnings (Normalized)
39.2127.5647.42
Price/Book Value
3.334.055.21
Price/Sales
4.563.946.32
Price/Cash Flow
22.6422.1640.38
Price/Earnings
ATRI
MMSI
STAA

Financial Strength

Metric
ATRI
MMSI
STAA
Quick Ratio
2.864.224.99
Current Ratio
9.186.035.84
Interest Coverage
6.17
Quick Ratio
ATRI
MMSI
STAA

Profitability

Metric
ATRI
MMSI
STAA
Return on Assets (Normalized)
7.67%9.17%7.37%
Return on Equity (Normalized)
8.36%15.14%9.21%
Return on Invested Capital (Normalized)
8.10%10.93%7.12%
Return on Assets
ATRI
MMSI
STAA
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
WrzqwndfqVhqx$163.9 Bil
Becton Dickinson & Co
BDX
DkydwwdhjHsmbqc$66.8 Bil
Alcon Inc
ALC
ZslrcxvMfqfxp$44.6 Bil
ResMed Inc
RMD
WspxcltgkRljrp$30.5 Bil
Coloplast A/S ADR
CLPBY
YhskslqdQmbm$28.9 Bil
West Pharmaceutical Services Inc
WST
JyxcbqtjwBcpz$23.3 Bil
Hologic Inc
HOLX
KzhyxlpsKznlbmc$18.3 Bil
The Cooper Companies Inc
COO
YggxkxkHgjkqht$18.2 Bil
Baxter International Inc
BAX
PnfnndjtsTxywqwp$18.0 Bil
Teleflex Inc
TFX
SlzFdlny$10.5 Bil

Sponsor Center